MARKER THERAPEUTICS
Live / Registered — Registered (as of 17 Sept 2024)
What this means for you
Registered since 17 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87832107
- Registration number
- 7507827
- Mark type
- Stylized text
- Filed
- 13 Mar 2018
- Published for opposition
- 19 Jan 2021
- Registered
- 17 Sept 2024
- Attorney of record
- TYE BIASCO
Goods and services
- Class 005 — Pharmaceuticals: T-cell pharmaceutical products for the treatment of cancer
- Class 042 — Scientific and technological services: Biotechnology services, namely, the development of T-cell pharmaceutical products and technologies for use in the treatment of cancer
Owner
- Marker Therapeutics, Inc., New Brighton, MN, US
- Marker Therapeutics, Inc., New Brighton, MN, US
- Marker Therapeutics, Inc., New Brighton, MN, US
Prosecution history
- 17 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 13 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Apr 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Mar 2024 — USE AMENDMENT FILED
- 05 Apr 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Mar 2024 — TEAS STATEMENT OF USE RECEIVED
- 23 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Sept 2023 — SOU EXTENSION 5 GRANTED
- 18 Sept 2023 — SOU EXTENSION 5 FILED
- 22 Sept 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Sept 2023 — SOU TEAS EXTENSION RECEIVED
- 14 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Mar 2023 — SOU EXTENSION 4 GRANTED